Laboratory items | Survivors | Non-survivors | p value | Cerebral damage | No cerebral damage | p value |
---|---|---|---|---|---|---|
Haemoglobin (g/L) | 114.2 ± 17.4 | 113.6 ± 21.6 | 0.78 | 118.5 ± 23 | 111.3 ± 16.2 | 0.13 |
Platelet count (109/L) | 177.9 ± 85.4 | 154.2 ± 94.2 | 0.11 | 149.7 ± 92.4 | 176.7 ± 88.4 | 0.09 |
aPTT (seconds) | 44.4 ± 12.1 | 56.7 ± 32.2 | 0.06 | 59.8 ± 34.4 | 44.4 ± 13.3 | 0.012 |
PTT ratio | 1.3 ± 0.4 | 1.6 ± 0.9 | 0.14 | 1.7 ± 1 | 1.3 ± 0.4 | 0.008 |
INR | 1.7 ± 0.6 | 1.7 ± 0.4 | 0.75 | 1.7 ± 0.4 | 1.7 ± 0.6 | 0.75 |
Fibrinogen (g/L) | 3.5 ± 1.4 | 3 ± 1.1 | 0.24 | 2.9 ± 1.3 | 3.5 ± 1.2 | 0.006 |
Base excess (mmol/L) | − 6.1 (− 10.2 to − 5.4) | − 10.1 (− 13 to − 7.7) | < 0.001 | − 10.1 (− 12.9 to − 7.2) | − 7 (− 11.2 to − 5.6) | 0.004 |
Pre-ECMO lactate (mmol/L) | 4.4 ± 1.5 | 7.2 ± 2 | < 0.001 | 6.8 ± 2.2 | 5.3 ± 2.1 | 0.001 |
Peak lactate level (mmol/L) | 11 ± 3 | 16.7 ± 3.3 | < 0.001 | 16 ± 3.9 | 12.8 ± 4 | < 0.001 |
Lactate at 24 h (mmol/L) | 2.2 ± 0.9 | 7.9 ± 5.7 | < 0.001 | 7.8 ± 6 | 3.5 ± 3.3 | < 0.001 |
Serum creatinine (μmol/L) | 96.4 ± 46 | 125.5 ± 74.2 | 0.018 | 117.5 ± 74.9 | 109 ± 55.6 | 0.87 |
Serum bilirubin (μmol/L) | 28.6 (15.7–58.7) | 37 (22–61.7) | 0.09 | 31.9 (22.8–55.1) | 29.5 (15.7–58.9) | 0.51 |
Serum albumin (g/L) | 34.3 ± 5.9 | 31.4 ± 5.5 | 0.007 | 30.9 ± 6.3 | 34.1 ± 5 | 0.012 |